Clinical Pharmacology, Development & Regulation

drug recall

A drug recall is the removal of a medicine from the market or from pharmacy shelves because something has gone wrong with its safety or quality. If approval is the green light that lets a drug be sold, a recall is the emergency brake, pulling the product back when continuing to use it is judged more dangerous than helpful.

Recalls fall broadly into two kinds. One is a quality or manufacturing problem affecting specific batches, such as contamination, the wrong amount of active ingredient, or a labeling mistake; here the drug itself is fine but particular lots are not. The other is a safety problem with the drug as a whole, where post-marketing evidence reveals a serious hazard, sometimes leading regulators to withdraw the product entirely.

A recall can be initiated by the manufacturer voluntarily or ordered or strongly pressed by a regulator, and they are usually graded by severity, from minor labeling issues up to defects that could cause serious harm or death. Once underway, the action ripples outward: distribution stops, wholesalers and pharmacies return stock, and patients may be advised to stop the drug and switch to an alternative.

Recalls are a sign the safety system is working, not merely that it failed. They depend on the continuous monitoring that watches drugs after approval, and on companies and regulators acting on what it finds. The honest tension is that pulling a drug also removes a treatment some patients relied on, so the decision weighs the harm of keeping it against the harm of taking it away.

Several blood-pressure medicines were recalled worldwide after manufacturing batches were found to contain a probable cancer-causing impurity formed during synthesis.

A manufacturing impurity can trigger a recall even when the drug itself is sound.

A batch recall pulls only specific defective lots, whereas a market withdrawal removes the drug itself; the two are often loosely called recalls together.

Also called
drug withdrawal药品撤回藥品撤回